stockrowAdaptive Biotechnologies Corporation (ADPT) vs RadNet, Inc. (RDNT)
- Adaptive Biotechnologies Corporation ADPT 26.96 +0.94%
- RadNet, Inc. RDNT 78.45 −2.26%
Adaptive Biotechnologies Corporation and RadNet, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $6.1B against $4.3B — 1.4× the size. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against 17.9%. RadNet, Inc. has the higher net margin (−0.93% vs −23.7%) and the higher return on invested capital (2.24% vs 0.00%). Across the 18 metrics below, RadNet, Inc. leads on 13 and Adaptive Biotechnologies Corporation on 5.
Valuation
Profitability
| Metric | ADPT | RDNT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 11.53% | 48.32% |
| Operating margin | (16.18%) | 3.12% | (5.68%) |
| Net margin | (23.66%) | (0.93%) | (4.10%) |
| Free cash flow margin | (2.96%) | 3.28% | 0.00% |
| Return on equity | (36.34%) | (1.64%) | 0.00% |
| Return on assets | (12.02%) | (0.55%) | (6.05%) |
| Return on invested capital | 0.00% | 2.24% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack